DarioHealth Corp.
DarioHealth Corp. (DRIO): 4 pipeline candidates · ~11 mo cash runway. Updated within the last hour.
BioSniper Score
3-factor signal · derived from public data
11.1 months
0% dilution
N/A
4 candidates
N/A
N/A
A transparent, data-derived signal for DarioHealth Corp.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$52.2M
Cash
$15.0M
Quarterly Burn
$6.0M
Runway
11.1 mo
Revenue
$5.6M
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| dario connect | — |
| dario health | — |
| dario mind | — |
| dario move | — |
Frequently asked questions
How many drug candidates are in DarioHealth Corp.'s pipeline?
DarioHealth Corp. (DRIO) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is DarioHealth Corp.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, DarioHealth Corp. has approximately 11.1 months of cash runway.
What is DarioHealth Corp.'s market capitalization?
DarioHealth Corp.'s market capitalization is approximately $52.2M.
Who is the CEO of DarioHealth Corp.?
Mr. Erez Raphael is the chief executive officer of DarioHealth Corp. (DRIO).
Get the full picture on DarioHealth Corp.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.